VISEN Pharmaceuticals

VISEN Pharmaceuticals

2.10
USD
- -
- -
Apr 01Next Earn

Important Dates

VISEN PHARMACEUTICALS's next confirmed earnings release is scheduled for April 1, 2027.

Earnings Date4/1/2027

Share Statistics

As of June 30, 2026, VISEN PHARMACEUTICALS has 109.30M shares outstanding.

Shares Outstanding109.30M

Financial Position

As of June 30, 2026, VISEN PHARMACEUTICALS maintains a current ratio of 4.00, meaning it holds 4.0x the short-term assets needed to cover near-term liabilities.

Current Ratio4.00
Quick Ratio2.38
Debt / Equity26.33

Financial Efficiency

These figures cover the twelve months ended June 30, 2026.

Employee Count82.00

Balance Sheet

USD

As of June 30, 2026, VISEN PHARMACEUTICALS holds 74.55M in cash and equivalents against 26.05M in total debt, resulting in a net debt position of -49.48M. Total book value stands at 98.94M, with working capital of 93.93M providing operational flexibility.

Cash & Cash Equivalents74.55M
Total Debt26.05M
Net Debt-49.48M
Equity (Book Value)98.94M
Book Value Per Share0.91
Working Capital93.93M